ArticleBMC cancer2016

Systematic drug screening reveals specific vulnerabilities and co-resistance patterns in endocrine-resistant breast cancer.

Sara Kangaspeska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.